单细胞RNA测序揭示聚乙二醇干扰素α对慢性乙型肝炎患者的免疫调节作用
本研究对慢性乙型肝炎患者接受聚乙二醇干扰素α治疗前后的外周免疫细胞进行单细胞RNA测序,鉴定出三种与HBsAg正相关的慢性乙型肝炎特异性细胞亚群;治疗减弱了过度活化单核细胞比例,增加了长寿命初始/记忆T细胞比例,增强了效应T细胞细胞毒性,并使整体免疫细胞转录谱由TNF驱动转向IFN-α驱动。
要点
- 鉴定出三种慢性乙型肝炎特异性细胞亚群:促炎CD14+单核细胞、促炎CD16+单核细胞和IFNG+ CX3CR1- NK细胞,高表达促炎基因并与HBsAg正相关。
- 聚乙二醇干扰素α治疗减弱过度活化单核细胞比例,增加长寿命初始/记忆T细胞比例,增强效应T细胞细胞毒性。
- 聚乙二醇干扰素α使整体免疫细胞转录谱由TNF驱动转向IFN-α驱动,并增强病毒感知和抗原呈递等先天抗病毒反应。
核心结论
- 本研究拓展了对慢性乙型肝炎病理特征及聚乙二醇干扰素α免疫调节作用的理解,为慢性乙型肝炎的临床诊断和治疗提供了新的有力参考。
研究设计与样本
- 应用单细胞RNA测序描绘慢性乙型肝炎患者接受聚乙二醇干扰素α治疗前后的外周免疫细胞转录组图谱。
主要发现
- 鉴定出三种慢性乙型肝炎特异性细胞亚群:促炎CD14+单核细胞、促炎CD16+单核细胞和IFNG+ CX3CR1- NK细胞,高表达促炎基因并与HBsAg正相关。
- 聚乙二醇干扰素α治疗减弱过度活化单核细胞比例,增加长寿命初始/记忆T细胞比例,增强效应T细胞细胞毒性。
- 聚乙二醇干扰素α治疗使整体免疫细胞转录谱由TNF驱动转向IFN-α驱动,增强包括病毒感知和抗原呈递在内的先天抗病毒反应。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Chronic hepatitis B (CHB) is caused by HBV infection and affects the lives of millions of people worldwide by causing liver inflammation, cirrhosis, and liver cancer. Interferon-alpha (IFN-α) therapy is a conventional immunotherapy that has been widely used in CHB treatment and achieved promising therapeutic outcomes by activating viral sensors and interferon-stimulated genes (ISGs) suppressed by HBV. However, the longitudinal landscape of immune cells of CHB patients and the effect of IFN-α on the immune system are not fully understood. APPROACH AND RESULTS: Here, we applied single-cell RNA sequencing (scRNA-seq) to delineate the transcriptomic landscape of peripheral immune cells in CHB patients before and after PegIFN-α therapy. Notably, we identified three CHB-specific cell subsets, pro-inflammatory (Pro-infla) CD14+ monocytes, Pro-infla CD16+ monocytes and IFNG+ CX3CR1- NK cells, which highly expressed proinflammatory genes and positively correlated with HBsAg. Furthermore, PegIFN-α treatment attenuated percentages of hyperactivated monocytes, increased ratios of long-lived naive/memory T cells and enhanced effector T cell cytotoxicity. Finally, PegIFN-α treatment switched the transcriptional profiles of entire immune cells from TNF-driven to IFN-α-driven pattern and enhanced innate antiviral response, including virus sensing and antigen presentation. CONCLUSIONS: Collectively, our study expands the understanding of the pathological characteristics of CHB and the immunoregulatory roles of PegIFN-α, which provides a new powerful reference for the clinical diagnosis and treatment of CHB.
引用
- Jiang P, Jia H, Qian X, et al. Single-cell RNA sequencing reveals the immunoregulatory roles of PegIFN-α in patients with chronic hepatitis B. Hepatology. 2023. PMID: 37368993. doi:10.1097/HEP.0000000000000524
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。